Back

Role of cardiovascular comorbidities in heart failure across the ejection fraction spectrum

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Heart failure treatment, HFpEF, HFmrEF Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Camilla Settergren

Karolinska Institute, Stockholm (Sweden)

9 More presentations in this session

Presentation thumbnail
Effect of beta-blockers on mortality in heart failure with mid-range and preserved ejection fraction: a meta-analysis
Associate Professor H. Fukuta (Nagoya, JP)
Abstract
Presentation thumbnail
Comparative efficacy of renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with reduced, mid-ranged and preserved ejection fraction
Professor L. Tumasyan (Yerevan, AM)
Abstract Slides
Presentation thumbnail
The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction
Doctor C. Wei-Ting (Tainan, TW)
Abstract Slides
Presentation thumbnail
Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study
Doctor K. Tsukamoto (Tokyo, JP)
Abstract
Presentation thumbnail
Natriuretic peptides added to clinical parameters predict two-year prognosis of patients with chronic heart with mid-range and reduced ejection fraction.
Professor J. Spinar (Brno, CZ)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Heart failure treatment, HFpEF, HFmrEF

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources